RETRACTION: lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer (Retraction of Vol 19, Pg 643, 2020)

被引：1
|
作者：
Chen, Xiliu
Wang, Zhongliang
Tong, Fan
Dong, Xiaorong
Wu, Gang
Zhang, Ruiguang
机构：
来源：
MOLECULAR THERAPY NUCLEIC ACIDS | 2024年 / 35卷
关键词：
D O I：
10.1016/j.omtn.2024.102215
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer
    Chen, Xiliu
    Wang, Zhongliang
    Tong, Fan
    Dong, Xiaorong
    Wu, Gang
    Zhang, Ruiguang
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 19 : 643 - 653
  • [2] lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer
    Li, Zewu
    Niu, Huanfu
    Qin, Qianqian
    Yang, Sanhui
    Wang, Qin
    Yu, Chunna
    Wei, Zefeng
    Jin, Zhenzhen
    Wang, Xuenan
    Yang, Aijun
    Chen, Xiaoli
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 17 : 92 - 101
  • [3] RETRACTION: LncRNA SENCR promotes cell proliferation and progression in non-small-cell lung cancer cells via sponging miR-1-3p (Retraction of Vol 20, Pg 1402, 2021)
    Cheng, Ruirui
    Zhang, Guowei
    Bai, Yong
    Zhang, Furui
    Zhang, Guojun
    CELL CYCLE, 2022, 21 (24) : 2666 - 2666
  • [4] RETRACTION: Long noncoding RNA UCA1 promotes cell growth, migration, and invasion by targeting miR-143-3p in oral squamous cell carcinoma (Retraction of Vol 9, Pg 3115, 2020)
    Duan, Q.
    Xu, M.
    Wu, M.
    Zhang, X.
    Gan, M.
    Jiang, H.
    CANCER MEDICINE, 2024, 13 (11):
  • [5] RETRACTION: Aberrant miR-1246 expression promotes radioresistance in non-small cell lung cancer: a potential prognostic biomarker and radiotherapy sensitization target (Retraction of Vol 10, Pg 314, 2020)
    Fan, L. Y.
    Wang, J.
    Cao, Q.
    Ding, X. P.
    Li, B. S.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (08): : 2689 - 2689
  • [6] LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis
    Chen, Huiyong
    Wang, Linhui
    Liu, Jingting
    Wan, Zihao
    Zhou, Lin
    Liao, Hongliang
    Wan, Renping
    CANCER BIOLOGY & THERAPY, 2023, 24 (01)
  • [7] RETRACTION: The miR-599 promotes non-small cell lung cancer cell invasion via SATB2 (Retraction of Vol 485, Pg 35, 2017)
    Tian, Wenjun
    Wang, Guanghai
    Liu, Yiqing
    Huang, Zhenglan
    Zhang, Caiqing
    Ning, Kang
    Yu, Cuixiang
    Shen, Yajuan
    Wang, Minghui
    Li, Yuantang
    Wang, Yong
    Zhang, Bing Chang
    Zhao, Yaoran
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 515 (04) : 733 - 733
  • [8] RETRACTION: Retraction Note: LINC01089 functions as a ceRNA for miR-152-3p to inhibit non-small lung cancer progression through regulating PTEN (Retraction of Vol 21, Pg 143, 2021)
    Zhang, Huixian
    Zhang, Hao
    Li, Xingya
    Huang, Siyuan
    Guo, Qianqian
    Geng, Di
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [9] LncRNA UCA1 Induces Acquired Resistance to Gefitinib by Epigenetically Silencing CDKN1A Expression in Non-small-Cell Lung Cancer
    Xu, Tianwei
    Yan, Shuai
    Wang, Mengwei
    Jiang, Lihua
    Ma, Pei
    Lu, Binbin
    Chen, Qinnan
    Wei, Chenchen
    Wang, Zhaoxia
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [10] RETRACTION: LncRNA TTN-AS1 promotes endometrial cancer by sponging miR-376a-3p ( vol 44, pg 1343, 2020)
    Shen, Longde
    Wu, Yinyin
    Li, Ailu
    Li, Lichun
    Shen, Longyuan
    Jiang, Qiuxia
    Li, Qiuxia
    Wu, Zhifen
    Yu, Liji
    Zhang, Xiaohong
    ONCOLOGY REPORTS, 2024, 52 (06)
12345